Monday's Late-Breaking Science presentations

Newsletter Card Late Breaking

8-9 a.m. EST

LBS.06 | Fish Oil and Cholesterol: Recipes for CVD Prevention?

  • Icosapent Ethyl Versus Placebo in Outpatients With COVID-19: The Main Results of PREPARE-IT 2 (PREPARE-IT 2)
  • The Clinical Safety, Pharmacokinetics, and LDL-Cholesterol Lowering Efficacy of MK-0616, an Oral PCSK9 Inhibitor

11 a.m.-Noon EST

LBS.07 | New Drugs and New Drug Indications in Cardiovascular Disease

  • Effects Of Aspirin on Dementia and Cognitive Impairment in the ASCEND Trial (ASCEND)
  • P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With COVID-19 (ACTIV-4A)
  • Effect Of Bentracimab on Platelet Inhibition and Hemostasis in Ticagrelor Patients With Uncontrolled Hemorrhage or Requiring Urgent Surgery in the REVERSE-IT (REVERSE-IT)
  • Milvexian for Prevention of Venous Thromboembolism After Elective Knee Arthroplasty: The AXIOMATIC-TKR Study (AXIOMATIC-TKR)